Filing Flows › VitaNova Life Sciences (VNOV) › Q4 FY25
VitaNova Life Sciences (VNOV) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Jul 24, 2025
VitaNova Life Sciences (VNOV) reported revenue of $2.0M for the fourth quarter fiscal 2025 (Q4 FY25), +259% from a year earlier and +533% from the quarter before. Operating margin was 55.4%, net earnings $800K (41.0% of revenue).
VitaNova Life Sciences, Q4 FY25: revenue $2.0M (+259% year over year), operating margin 55.4%, net earnings $800K, operating cash flow $479K. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | +533% | +259% |
| Gross profit | $1.2M | +511% | +229% |
| Operating profit | $1.1M | +894% | +365% |
| Net earnings | $800K | +997% | +377% |
| Operating cash flow | $479K | +129% | — |
What changed
Revenue was $2.0M in Q4 FY25, up 259% year over year and up 533% from the previous quarter.
Gross margin was 59.3%, down 5.3 points from a year earlier. Operating profit was $1.1M, a 55.4% margin (up 12.7 points year over year). Of the extra revenue versus a year earlier, 60% reached operating profit, above the 43% margin then. Operating expenses fell 37% while revenue rose 259%. Net earnings were $800K, up 377% year over year. The effective tax rate was 25.9%.
Operating cash flow was $479K, 60% of net earnings. Working capital and other items used $321K.
Questions
What was VitaNova Life Sciences' revenue in the fourth quarter fiscal 2025?
VitaNova Life Sciences (VNOV) reported revenue of $2.0M for the fourth quarter fiscal 2025 (Q4 FY25), +259% from a year earlier and +533% from the quarter before.
Was VitaNova Life Sciences profitable in the fourth quarter fiscal 2025?
Operating profit was $1.1M (55.4% of revenue) and net earnings $800K.